Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

This study is evaluating a fractional ablative laser device for treating skin conditions including skin laxity (looseness) and scarring. Fractional lasers work by targeting thousands of tiny columns of skin with energy while leaving surrounding skin intact, stimulating collagen remodeling and tissue tightening. Researchers want to assess the safety, effectiveness, and cosmetic outcomes of this laser treatment across patients with various skin types and conditions. To participate, you must be between 18 and 85 years old, have visible skin laxity or a scar in the treatment area, be able to read and understand English, and for women, be post-menopausal, surgically sterilized, or using reliable contraception. Exclusion criteria include prior cosmetic treatments to the same area, history of skin cancer in that area, active infections or wounds, pregnancy or breastfeeding, uncontrolled diabetes or cardiovascular disease, blood clotting disorders, history of keloid scarring, immunosuppression, certain skin diseases, and current or recent smoking. Participants will receive laser treatments and be followed up with photographic documentation and outcome assessments. This research is important because skin laxity and scarring affect quality of life and self-esteem for many people, and optimizing laser treatment protocols — in terms of both effectiveness and safety across different skin types — helps clinicians deliver more consistent and favorable cosmetic results.